SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-005130
Filing Date
2021-02-16
Accepted
2021-02-16 21:57:27
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 form5.html 5  
1 FORM 5 form5.xml 5 14747
  Complete submission text file 0001140361-21-005130.txt   16093
Mailing Address
Business Address
GRANADILLO PEDRO P (Reporting) CIK: 0001217544 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36829 | Film No.: 21642458

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations